International treatment guidelines – from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) – have advised that prevention of exacerbations should be a cornerstone of COPD management, placing equal emphasis on the management of future risk as it does on treatment of COPD symptoms.1 This is also confirmed in the latest data on the impact of season on the frequency of COPD exacerbations, showing an almost two-fold increase in the winter months. This is contributing to the increased morbidity seen during the festive season.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/nycomedtakeda/52782/
Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the HomeLox portable liquid oxygen system. The innovative system enables oxygen users to generate and store the liquid form of oxygen in the home setting. The HomeLox system offers users the long-lasting and lightweight characteristics of traditional liquid systems, while freeing them from difficulties of filling and dependence on deliveries associated with conventional systems.
Home oxygen is a critical, life-sustaining medical treatment prescribed to nearly 1.5 million Medicare patients annually who suffer from respiratory illnesses such as chronic obstructive pulmonary disease (COPD).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/philips/45648/
National health initiative DRIVE4COPD today announced the launch of its new Ambassador Program, which gives fans the opportunity to join their favorite celebrity in a common cause: raising awareness of chronic obstructive pulmonary disease (COPD). The Ambassador Program marks the beginning of the Great American Screen Off, a nationwide push this fall to screen Americans for their risk of COPD at DRIVE4COPD.COM. Fans can now enter the DRIVE4COPD Celebrity Race Team’s ongoing competition to see who can screen the most people.
To view Multimedia News Release, go to http://www.multivu.com/players/English/46007-boehringer-ingelheim-great-american-screen-off/
The American Lung Association has released an edgy public service advertising (PSA) campaign featuring provocative television, online and out-of-home components to encourage people to download the charity’s new State of the Air® smartphone application, a valuable resource for people living with lung disease like asthma and chronic obstructive pulmonary disease (COPD), people with heart disease or diabetes, as well as older adults and children. This is the first time that a charity has included an app download as the call to action in a nationally distributed PSA.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55128-american-lung-association-breathe-smarter-psa-air-quality-smartphone-app
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
Landmark public health campaign DRIVE4COPD announced today that Tim Wright was chosen from more than 150 entries as the winner of the Tune Up for COPD Songwriting Competition. DRIVE4COPD Celebrity Ambassadors Billy Ray Cyrus and Patty Loveless were among the judges for the competition, launched in partnership with the Country Music Association (CMA), which challenged Americans to create a new DRIVE4COPD song to help raise awareness of chronic obstructive pulmonary disease (COPD).
To view Multimedia News Release, go to http://www.multivu.com/players/English/48274-boehringer-ingelheim-tuneupforcopd/
Hollywood, sports and music stars brought the public along for the ride as they raced 6,000 miles in four days to find the millions of people who may be at risk for Chronic Obstructive Pulmonary Disease (COPD), which kills one person every four minutes. Through Twitter, Facebook, Flickr and YouTube, tens of thousands of people followed the celebrities as they traveled to 14 cities to screen thousands of people for this relatively unknown top cause of death.
To view Multimedia News Release go to, http://multivu.prnewswire.com/mnr/drive4copd/41919/
The DRIVE4COPD national public health initiative today announced that it is partnering with the Country Music Association (CMA) to launch the Tune Up For COPD Songwriting Competition, featuring country music stars Billy Ray Cyrus and Patty Loveless. The competition challenges Americans to create a new DRIVE4COPD song to help raise awareness of chronic obstructive pulmonary disease (COPD). Last year, Loveless wrote the campaign anthem, 'Drive,' in honor of her sister Dottie, who died of COPD when she was only 48 years old.
To view Multimedia News Release, go to http://www.multivu.com/players/English/48274-boehringer-ingelheim-tuneupforcopd/
Ridgefield, CT, September 14, 2011 – Landmark public health campaign DRIVE4COPD today announced the unveiling of 24M: The DRIVE4COPD Monument, a visual representation of the impact of chronic obstructive pulmonary disease (COPD) in the United States. Reaching 14 feet at its highest peak and spanning half a football field, this first-of-its-kind monument comprised of 24 large-scale pinwheels to represent the 24 million Americans who may be living with COPD, was designed by internationally renowned artist and sculptor Michael Kalish.
To view Multimedia News Release, go to http://www.multivu.com/players/English/51245-24m-the-drive4copd-monument/
